28 Tiblad E, Wikman A, Rane A, Jansson Y, Westgren M.Pharmacokinetics of 250 mug anti-D IgG in the third trimesterof pregnancy: an observational study. Acta ObstetGynecol Scand 2012;91:587–92. (Level III) 29 Bowman JM. Con...
(percentage) levels below 11 g/dLand 33%, respectively, in the first trimester; 10.5 g/dLand 32%, respectively, in the second trimester; and 11g/dL and 33%, respectively, in the third trimester (1).Anemias may be categorized by whether they areinherited or acquired, underlying causative ...
She has had no vaginal bleeding, no nausea or vomiting. The patient's history is notable for two first trimester elective abortions and a history of Chlamydia treated twice. Vital signs are: blood pressure 90/60; pulse 99; respirations 22; and temperature 98.6°F (37°C). On physical ...
ACIP ACOG ACP ACR ACTRIMS ADA AES AHA AHNS AIBD AMA APA ASA ASCO ASH: Hematology ASHP ASN ASRM ASRS ASTRO ATS AUA CCC CHEST CROI CTAD DDW EASD EASL EAU EBCC ECTRIMS EHA ENDO ERS ESC ESMO ESMO Breast Cancer EULAR EuroPCR GICS
Tiblad E, Wikman A, Rane A, Jansson Y, Westgren M. Pharmacokinetics of 250 mug anti-D IgG in the third trimester of pregnancy: an observational study. Acta Obstet Gynecol Scand 2012;91:587–92. (Level III) 29 Bowman JM. Controversies in Rh prophylaxis. Who needs Rh immune globulin and...
It causes more disruption in menstrual bleeding, especially during the first few months of use, although the overall volume of bleeding is decreased long-term and many women become amenorrheic. The levonorgestrel intrauterine device is protective against endometrial cancer due to release of progestin ...
Stedman CM, Quinlan RW, Huddleston JF, Cruz AC,Kellner KR. Rh sensitization after third-trimester fetaldeath. Obstet Gynecol 1988;71:461–3. (Level III) 79 Ness PM, Baldwin ML, Niebyl JR. Clinical high-riskdesignation does not ...